936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+ patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2)
    Meeting Abstract

    D'Angelo, S. P.; Noujaim, J. C.; Thistlethwaite, F.; Razak, A. R. A.; Stacchiotti, S.; Chow, W. A.; Haanen, J. B. A. G.; Chalmers, A. W.; Robinson, S. I.; Van Tine, B. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase (Ph) 1b/2 evaluation of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Attia, S.; Villalobos, V. M.; Hindi, N.; Van Tine, B. A.; Wagner, A. J.; Chmielowski, B.; Levy, D. E.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Master protocol to assess safety and recommended phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma or non-small cell lung cancer (Substudies 1 and 2)
    Meeting Abstract

    Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S. P.; Ladle, B. H.; Noujaim, J. C.; He, K.; Liebner, D. A.; Sacher, A. G.; Haanen, J. B. A. G.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors
    Meeting Abstract

    LoRusso, P.; Gounder, M. M.; Patel, M. R.; Yamamoto, N.; Bauer, T. M.; Laurie, S.; Grempler, R.; Davenport, T.; Geng, J.; Rohrbacher, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Van Tine, B. A.; Attia, S.; Blay, J. Y.; Strauss, S. J.; Morales, C. M. V.; Razak, A. R. A.; Van Winkle, E.; Trivedi, T.; Biswas, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis
    Meeting Abstract

    D'Angelo, S. P.; Druta, M.; Van Tine, B. A.; Liebner, D. A.; Schuetze, S.; Hasan, A. N.; Holmes, A. P.; Huff, A.; Kapoor, G. S.; Zajic, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    D'Angelo, S. P.; Robinson, S. I.; Lam, J.; Adams, B. J.; Freddo, J. L.; Theuer, C. P.; Maki, R. G.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Imaging-based patient inclusion model for clinical trial performance optimization
    Meeting Abstract

    Tomaszewski, M. R.; Fan, S.; Qi, J.; Garcia, A.; Kim, Y.; Schabath, M. B.; Gatenby, R. A.; Tap, W. D.; Reinke, D. K.; Makanji, R. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations
    Meeting Abstract

    Dickson, M. A.; Ravi, V.; Ganjoo, K. N.; Iyer, G.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save